SOPHARMA AD (31/2023) Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Report no 31/2023
- 05.06.2023, 10:15
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (30/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Report no 30/2023- 05.06.2023, 10:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (29/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Report no 29/2023- 05.06.2023, 09:57
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (27/2023) Notification on the terms and conditions for distribution of the dividend
Report no 27/2023- 02.06.2023, 13:43
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (26/2023) Analysis of potential acquisition opportunities on the territory of the Republic of Serbia
Report no 26/2023- 01.06.2023, 13:45
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (25/2023) Consolidated financial report according to IFRS as at 31 March 2023
Report no 25/2023- 30.05.2023, 13:31
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (24/2023) Sales revenues for April 2023
Report no 24/2023- 22.05.2023, 13:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (23/2023) Invitation and materials for a General shareholders meeting
Report no 23/2023- 28.04.2023, 16:38
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (22/2023) 2022 Annual Consolidated Financial Report - ESEF format
Report no 22/2023- 28.04.2023, 16:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
